Current Trends and Future Perspectives for Enhanced Drug Delivery to Central Nervous System in Treatment of Stroke
Therapeutic Delivery · 2023
DOI: 10.4155/tde-2022-0064 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Delivery, 2023. Verfasst von Rajalakshmi Rajendran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi- 682041, Kerala, India. Hauptthemen laut MEDLINE: Metal Nanoparticles, Nanostructures, Stroke, Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 149 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Stroke, one of the leading causes of death around the globe, is expected to rise considerably by 2050. The expanding nanotechnology science offers a promising future for medical research treating stroke. Nanomaterials are expanding their application in stroke management by structure and function as in perfluorocarbon, iron oxide nanoparticles, gold nanoparticles, dendrimers, quantum dots, nanospheres, and other organic and inorganic nanostructures. Nanotechnology integrated with stem-cell therapy is a different hit in stroke treatment. Nonetheless, some challenges must be resolved before globalizing the use of nanomaterials in stroke treatment and other neurological disorders. A stroke is an emergency medical condition that affects the brain. Stroke is the third leading cause of death in the US and fifth in other developing countries. Taking blood-clotting medicines, helps relieve symptoms by preventing blood clots. However, they cannot treat the cause of the disease that is causing them. Therefore, using body fluids for identifying and treating strokes will give better results. In general, giving medicine to the brain is difficult, and it is a big challenge. Nanosized small molecules help to overcome this problem. This review aims to summarize how stroke is managed and how these molecules can help.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi- 682041, Kerala, India.
ORCID-Profile: Rajalakshmi Rajendran, Arundhasree Kunnil, Sreeja Chandrasekharan Nair
Zitieren
APA
Rajendran, R., Kunnil, A., Radhakrishnan, A., Thomas, S., & Nair, S. C. (2023). Current Trends and Future Perspectives for Enhanced Drug Delivery to Central Nervous System in Treatment of Stroke. Therapeutic Delivery. https://doi.org/10.4155/tde-2022-0064
Vancouver
Rajendran R, Kunnil A, Radhakrishnan A, Thomas S, Nair SC. Current Trends and Future Perspectives for Enhanced Drug Delivery to Central Nervous System in Treatment of Stroke. Therapeutic Delivery. 2023. doi:10.4155/tde-2022-0064
BibTeX
@article{Rajendran2023,
author = {Rajendran, Rajalakshmi and Kunnil, Arundhasree and Radhakrishnan, Aiswarya and Thomas, Sachin and Nair, Sreeja Chandrasekharan},
title = {Current Trends and Future Perspectives for Enhanced Drug Delivery to Central Nervous System in Treatment of Stroke},
journal = {Therapeutic Delivery},
year = {2023},
doi = {10.4155/tde-2022-0064}
}
EUVIMED